Dara Mohsenian

Keurig Dr Pepper Presents 'Compelling' Valuation Despite Coffee Softness, Says Morgan Stanley Analyst
Coca-Cola Analysts Remain Optimistic As Shares Stagnate Despite Impressive First-Quarter Earnings
Is Now The Time To Invest In Defensive Stocks?
Coca-Cola Analysts Remain Optimistic As Shares Stagnate Despite Impressive First-Quarter Earnings
Is Now The Time To Invest In Defensive Stocks?
Why This Constellation Brands Analyst Sees Beer Rebound Ahead
Monster Beverage's Growth Prospects Underappreciated, Morgan Stanley Says In Upgrade

Dara Mohsenian Recent News

Morgan Stanley Turns Bullish On Coca-Cola, Sees Encouraging Signs In Q2 Report
Beverage giant Coca-Cola Co (NYSE: KO) is trading at an "outsized valuation discount" versus its peers, and investors should take advantage of the compelling valuation gap, according to Morgan Stanley.
Morgan Stanley Downgrades Coca-Cola And Monster Beverages
Morgan Stanley Upgrades Keurig Dr Pepper On Improved Valuation
Morgan Stanley Needs An 'Energy Boost,' Upgrades Monster Beverage
Morgan Stanley: Buy PepsiCo's Fizz Over Keurig Dr Pepper
Morgan Stanley Met With Coca-Cola's CFO And Left Satisfied
Morgan Stanley Upgrades Mondelez On Improved Top-Line Growth Outlook
The Street's Wide-Ranging Take On Molson Coors Earnings, CEO Change
Morgan Stanley: Coca-Cola 'Clearly' Boasts Better Growth
Morgan Stanley's Beverage Pair Trade: Overweight Coca-Cola, Underweight Keurig Dr Pepper
Morgan Stanley Upgrades Coca-Cola, Sees More Growth Ahead
Coca-Cola's Outlook Has Analysts Perking Up
Keurig Losing Buzz, Morgan Stanley Says In Downgrade
Analyst: Kellogg Trims The Fat By Selling Keebler, Other Snack Brands
Morgan Stanley Upgrades Kraft Heinz, Boosts Stock
Estee Lauder: Analysts Mostly Bullish On Q2 Results, Despite Weak Guidance
Procter & Gamble Is Now A Top Pick At Morgan Stanley
As Coke Shakes Up Energy Drink Category, Monster Earns A Downgrade
The Beauty Sector: Morgan Stanley Turns Bullish On Estee Lauder, Coty
Morgan Stanley To Kimberly-Clark Investors: These Headwinds Are Too Notable To Ignore
Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness
Morgan Stanley Catches Flack For Colgate-Palmolive Upgrade
Don't Brush Off An Opportunity To Buy Colgate-Palmolive Right Now